The structure of your deal matters as much as the price. How the transaction is built determines your tax exposure, your liability after closing, and how much of the purchase price you actually keep. Most healthcare sellers spend the bulk of their time negotiating valuation and far too little time understanding the structural options before them. Before you sit across from a buyer, you need to understand why deal structure often has more financial impact than headline price, what the three primary structures look like, and what each one means for your risk, taxes, and post-close obligations.
Why Healthcare Deal Structuring Deserves Your Full Attention
Healthcare transactions entail regulatory and liability considerations that standard M&A guidance rarely fully addresses. Payer contracts, licensure, compliance history, and Stark Law exposure all interact with deal structure in ways that affect your outcome well beyond closing day.
Structural decisions made early are difficult to reverse. Once a letter of intent establishes the framework, buyers treat it as a baseline and rarely agree to material changes without something in return. That asymmetry means your position at the start of negotiations largely determines what you walk away with. Buyers and sellers typically have opposing structural preferences, and understanding why gives you the leverage to push back with logic rather than instinct.
Asset Sales: What You’re Selling and What You’re Keeping
In an asset sale, the buyer acquires specific assets of your practice rather than the legal entity itself. Those assets typically include equipment, patient records, contracts, and goodwill. The legal entity stays with you after closing, and so does most of the historical liability.
Malpractice claims, billing disputes, employment matters, and compliance issues tied to the entity before the transaction generally do not transfer. That is the primary reason buyers in healthcare strongly prefer asset deals. They acquire what they want without inheriting what they do not.
From a tax standpoint, asset sales tend to cost sellers more. Depending on how your practice is structured, a portion of the proceeds may be taxed as ordinary income rather than at capital gains rates. Goodwill typically receives favorable treatment, but other allocations, such as equipment and non-competes, often do not. The purchase price allocation is a negotiation, and how it lands directly affects your tax bill.
Stock Sales: Selling the Entire Entity
In a stock or equity sale, the buyer purchases your ownership interest in the legal entity. Everything inside that entity transfers: assets, contracts, liabilities, and history. You exit cleanly, and the buyer takes on the full picture.
Sellers generally prefer stock deals because proceeds are more likely to be taxed at long-term capital gains rates, which are lower than ordinary income rates for most sellers. On a sizable transaction, that difference represents real money.
Buyers take on more risk in a stock deal, and they price it that way. They often respond with aggressive representations and warranties requirements, indemnification provisions, or escrow holdbacks to protect against pre-closing issues that surface later. In some cases, they push for representations and warranties insurance to manage that exposure.
Stock sales do make practical sense in healthcare for one specific reason: payer contract and licensure continuity. When the entity does not change hands, Medicare, Medicaid, and commercial payor enrollment often stay intact without re-credentialing. That continuity has real operational value for buyers, which gives sellers additional leverage when making the case for a stock structure.
Earnouts: Bridging the Gap Between What You Think Your Practice Is Worth and What a Buyer Will Pay Today
An earnout defers a portion of the purchase price and ties it to the practice’s future performance after closing. If the practice hits agreed targets, you receive the additional payment. If it does not, you do not.
Common metrics in healthcare earnout structures include collections, revenue, patient volume, and EBITDA. Earnouts let buyers pay for performance they are not yet certain about, while allowing sellers to capture the full value they believe the practice will deliver.
Earnout disputes are common and often costly. The most frequent source of conflict is straightforward: you no longer control the business after closing. A buyer’s staffing decisions, billing practices, or operational changes can directly affect whether you hit the targets tied to your earnout, and your recourse is typically limited. Before agreeing to any earnout provision, ask how performance metrics are defined and measured, who controls the decisions that drive those metrics, what reporting you will receive, and what happens if the buyer changes the operating model.
How Buyers Think About Structure, and Why It Should Inform Your Position
Buyers push for asset deals because they limit inherited liabilities and often provide favorable tax treatment through a step-up in the asset basis. Understanding that motivation helps you recognize what you are giving up when you agree to one without negotiating the terms.
Private equity acquirers and strategic buyers approach structure differently. Private equity firms are typically structured as sophisticated vehicles and move quickly to establish terms that favor their return profile. Strategic buyers such as health systems or larger group practices may have greater flexibility if the deal aligns with their long-term integration goals. Knowing which type of buyer you are dealing with shapes how you respond to their opening position.
Sellers often underestimate the leverage they carry. A clean compliance record, strong payer relationships, or a practice that would be difficult to re-credential can shift the conversation. If continuity matters to the buyer, the argument for a stock structure carries more weight than most sellers realize going in.
Choosing the Right Structure for Your Situation
Your entity type matters. C-corporations face double taxation in asset sales, which makes stock deals significantly more attractive. S corporations, LLCs, and partnerships each carry different structural implications that your tax advisor needs to model before you enter negotiations.
Your liability history matters too. If your practice carries compliance risk, unresolved billing disputes, or pending claims, buyers will price that into the deal or demand structural protection. Understanding your own exposure before a buyer finds it gives you time to address it or adjust your expectations accordingly.
Your post-close role shapes which structure works in your favor. If you are staying on as an operator, an earnout can be reasonable when you retain meaningful influence over performance. If you are exiting fully, earnouts introduce uncontrolled risk, and you should negotiate accordingly.
FAQs
Why do buyers prefer asset sales while sellers prefer stock sales?
Buyers favor asset sales because historical liabilities like malpractice claims and billing disputes stay with the seller, while sellers prefer stock sales because proceeds are typically taxed at lower long-term capital gains rates.
When does a stock sale make sense in a healthcare transaction?
When payer contract and licensure continuity matter, since keeping the legal entity intact often preserves Medicare, Medicaid, and commercial payer enrollment without re-credentialing.
What is the biggest risk of accepting an earnout?
You lose control of the business after closing, so the buyer’s staffing, billing, or operational decisions can determine whether you hit the targets tied to your deferred payment.
Structure the Deal Before Buyers Structure It for You
A strong purchase price can still produce a weak outcome if the structure shifts too much tax, liability, or post-close risk onto you. Before signing an LOI, understand how asset sales, stock sales, and earnouts affect what you keep, what you owe, and what you remain responsible for after closing. Enter negotiations with a structure that protects your position by working with Inflection 360’s acquisitions advisory support.
